13.27
0.00%
Close of 5 Nov 2026, in USD
About Mountain Crest Acquisition Corp V
From its filings with the US Securities and Exchange Commission
Mountain Crest Acquisition Corp V is based in New York, New York and is incorporated in Delaware. Its shares trade on OTC under the ticker MCAG. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported a net loss of $431,161. At that date it held total assets of $873,566 and shareholders' equity of −$3.7m.
On October 19, 2022, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”) with AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with company registration 201810204D (“AUM”).
The Business Combination Agreement was subsequently amended on February 10, 2023, March 30, 2023 and April 19, 2023. On January 27, 2023, AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limited by shares incorporated in Singapore, with company registration number 202238778Z and a direct, wholly-owned subsidiary of Holdco, and AUM Biosciences Delaware Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Holdco, executed a joinder agreement with the Company and AUM and joined the Business Combination Agreement as parties. The Business Combination Agreement would have provided, subject to its terms and conditions, for the initial business combination of the Company (the “Business Combination”). On May 22, 2023, the Company filed a definitive proxy statement on Schedule 14A, as amended on May 24, 2023 to solicit its stockholders’ voting on the Business Combination Agreement, among other proposals, at a special meeting of stockholders scheduled to be held on June 23, 2023 at 10:00 a.m., Eastern Time, or any postponement or adjournment.
Quoted from its 10-K, filed 16 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 12 Nov 2021
- Head office
- 524 BROADWAY, NEW YORK, NY, 10012
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Leadership
Pay as last reported
- Dr. Suying LiuChairman of the Board, Chief Executive Officer, Chief Financial Officer, since 2021
- Mr. Nelson HaightIndependent Director
- Dr. Todd MilbournIndependent Director
- Mr. Wenhua ZhangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Mountain Crest Acquisition Corp V targets private companies in North America.
- The firm focuses its search on businesses in Asia Pacific regions.
- Mountain Crest Acquisition Corp V is structured for various business combinations.
Weaknesses
- The firm is not engaged in any current business operations.
- Mountain Crest Acquisition Corp V has not generated any revenue.
- The company is a blank check company with no active operations.
Opportunities
- Mountain Crest Acquisition Corp V can effect a merger with businesses.
- The firm may execute a stock purchase with target companies.
- Mountain Crest Acquisition Corp V could complete a reorganization with partners.
Threats
- Mountain Crest Acquisition Corp V lacks any existing business operations.
- The firm has not generated any revenue since its formation.
- Mountain Crest Acquisition Corp V relies on finding a suitable target.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.